Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 21 October

Sophia Mavridis
October 21, 2022

Closing Bell 20 October

Grady Wulff
October 20, 2022

Morning Bell 20 October

Grady Wulff
October 20, 2022

Closing Bell 19 October

Grady Wulff
October 19, 2022

Morning Bell 19 October

Grady Wulff
October 19, 2022

Closing Bell 18 October

Grady Wulff
October 18, 2022

Morning Bell 18 October

Sophia Mavridis
October 18, 2022

Closing Bell 17 October

Grady Wulff
October 17, 2022

Morning Bell 17 October

Grady Wulff
October 17, 2022

Weekly Wrap 14 October

Grady Wulff
October 14, 2022

Morning Bell 14 October

Sophia Mavridis
October 14, 2022

Closing Bell 13 October

Grady Wulff
October 13, 2022